Epilepsy, even though limited to patients with surgical indications, may be the consequence of a wide range of disorders affecting the brain, including tumors and various non-neoplastic lesions.[1-4] In fact, a broad spectrum of structural brain lesions have been confirmed by a survey of 5392 epileptogenic brain tissue specimens surgically resected

from patients with drug-resistant localized epilepsies collected at the European Epilepsy Brain Bank.[5] selleck screening library These, in descending order of frequency, include hippocampal sclerosis (HS: 33.7%), long-term epilepsy-associated tumors (LEAT: 25.1%), malformations of cortical development (MCDs: 15.5%), vascular malformations (5.7%), dual pathologies (5.2%), glial scars (4.9%) and encephalitis (1.6%), as well as no lesion (8%). Besides LEAT, HS and MCDs are the two most frequent non-neoplastic lesions of drug-resistant focal epilepsies, constituting about 50% of all epilepsy surgery cases. In this review article, neuropathological features this website of these two lesions will be briefly

summarized, addressing the several distinct histological patterns that have historically been identified and classified in HS and focal cortical dysplasia (FCD). Furthermore, our recent attempt to construct a simplified classification system of HS based on the review of 41 surgical cases of mTLE, and neuropathological comparative study of mTLE-HS and dementia-associated Dichloromethane dehalogenase HS (d-HS) in the elderly, will also be addressed. Finally, HS occurs not infrequently

with a second lesion, including FCD. Current International League Against Epilepsy (ILAE) definitions of such combined HS and FCD will also be briefly summarized. Hippocampal sclerosis is the most frequent pathologic finding in én bloc resection specimens from patients, usually in their twenties and thirties or occasionally even forties, with long-standing pharmacoresistant mesial temporal lobe epilepsy (mTLE). The earliest pathological study of epilepsy dates back to the early 19th century. Bouchet and Cazauvielh in 1825 described macroscopic features of hard and shrunken hippocampus in autopsy brains from patients with an antemortem history of epilepsy.[6] Sommer in 1880 first described microscopic features of HS in an autopsy brain from a patient with mTLE.[7] He observed loss of pyramidal neurons in a portion of the hippocampus that was later on called “Sommer’s sector” corresponding to the sector CA1 of Lorente de Nó.[8] Sommer also noted some neuronal loss within the hilus of the dentate gyrus.